KineMed's Series E Round

KineMed raised a round of funding on January 21, 2010. Investors include Ledgemont Capital Group.

KineMed employs both pathway-based drug discovery and translational medicine-enabled drug development. KineMed's pathway-based discovery is based upon its ability to identify drugs with therapeutic ef…

Articles about KineMed's Series E Round: